91 results
8-K
EX-99.2
VANI
Vivani Medical Inc
14 Nov 23
Results of Operations and Financial Condition
6:06am
to support the initiation of the Company’s FIH study in that country. If available, Vivani intends to utilize research and development incentives … .
Research and development expense. Research and development expense increased by $0.5 million, or 15%, to $4.4 million in the third quarter of 2023 from
8-K
EX-99.1
VANI
Vivani Medical Inc
19 Mar 20
Second Sight Reports Fourth Quarter and Full Year 2019 Financial Results
4:15pm
quarter of 2018. During the fourth quarter of 2019, costs previously reported as cost of sales are reported in research and development expense … in connection with the Company’s changeover in production from Argus II commercial units to Orion prototypes.
Research and development expense, net
8-K
EX-99.1
mm8eqc8hq8seb5dexsp
26 Mar 24
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:31am
8-K
EX-99.2
tj6diiw g8
15 May 23
Results of Operations and Financial Condition
6:49am